Lewis Bender
Algemeen Directeur bij INTENSITY THERAPEUTICS, INC.
Vermogen: 10 M $ op 31-05-2024
Actieve functies van Lewis Bender
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Voorzitter | 01-04-2012 | - |
| Algemeen Directeur | 01-04-2012 | - | |
| Oprichter | 01-01-2012 | - | |
| Directeur/Bestuurslid | 01-01-2012 | - | |
| President | 01-01-2012 | - |
Loopbaan van Lewis Bender
Eerdere bekende functies van Lewis Bender
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTERLEUKIN GENETICS, INC | Directeur/Bestuurslid | 17-02-2011 | 23-08-2012 |
| Algemeen Directeur | 22-01-2008 | 23-08-2012 | |
| EMISPHERE TECHNOLOGIES, INC. | Algemeen Directeur | 01-01-1993 | 01-12-2007 |
| Hoofd Techniek/Wetenschap/O&O | 01-01-1993 | 01-12-2007 | |
| President | 01-01-1993 | 01-12-2007 |
Opleiding van Lewis Bender
| University of Pennsylvania | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| President | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
- Beurs
- Insiders
- Lewis Bender
- Ervaring
